Procurement Summary
Country: USA
Summary: Dow Tuberous Sclerosis Complex, Clinical Translational Research Award
Deadline: 06 Aug 2026
Posting Date: 06 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140728176
Document Ref. No.: HT942526TSCRPCTRA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Summary: The Fiscal Year 2026 (Fy26) Tuberous Sclerosis Complex Research Program (Tscrp) Clinical Translational Research Award (Ctra) Supports Studies That Will Move Promising, Well-Founded Preclinical And/Or Clinical Research Findings Closer To Clinical Application, Including Diagnosis, Prognosis Or Treatment Of Tuberous Sclerosis Complex (Tsc).Distinctive Features: This Funding Mechanism Allows For Multiple Principal Investigators (Pis). Only The Initiating Pi Will Submit A Pre-Application, But All Pis Will Need To Submit Full Applications. The Partnering Pi(S) Application Is An Abbreviated Package Specific To Their Distinct Portion Of The Research Project. Be Advised, All Associated Applications For A Research Project May Be Withdrawn If The Initiating Or Partnering Application Is Rejected Or Administratively Withdrawn.Eligibilityeligible Applicantsmiscellaneousunrestrictedadditional Informationgrantor Contact Informationdescriptionebrap Help Desk Phone: 301-682-5507 Email: [email protected] Help Deskdocumentsfile Namedescriptionlast Updatedfy26 Tscrp Ctra Program Announcementmay 5, 2026 07:19 Pm Utclink To Additional Information--Closing: August 6, 2026
Posted Date: 2026-05-05 00:00:00
Funding instrument type: Grant
Documents
Tender Notice